Intraocular Silicone Oil Versus Gas in the Management of PVR: A Multicenter Clinical Study

  • Walter H. Stern
  • John S. Lean
  • The Silicone Study Group

Abstract

Over the last two decades, a series of surgical procedures have been identified as being fundamental in the management of retinal detachment complicated by proliferative vitreoretinopathy (PVR). These procedures have included grading the severity of PVR,1–3 timing the surgery for the biological “window” in which to operate,4 the use of vitreous surgery to relieve retinal traction,5,6 the use of a broad scleral buckle to relieve anterior loop contraction and endolaser to achieve a widespread chorioretinal adhesion,7 and the use of an extended internal tamponade postoperatively.8–15 The Silicone Study was designed to answer a series of clinical questions regarding the surgical management of PVR using the methodology of a randomized clinical trial. This trial is attempting to answer these primary questions:
  1. (a)

    Do the visual acuity and anatomic reattachment results differ between eyes treated with silicone oil and those treated with gas?

     
  2. (b)

    Do the ocular complications that result from the use of silicone oil differ from those resulting from extended gas tamponade?

     
  3. (c)

    Does a relationship exist between an anatomic description of PVR and the retinal reattachment rate?

     
  4. (d)

    Can photographic documentation of PVR be utilized effectively to grade the extent and anatomy of PVR?

     

Keywords

Corticosteroid Propane Heparin Retina Assure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121.Google Scholar
  2. 2.
    Lewis H, Aaberg TM. Anterior proliferative vitreoretinopathy. Am J Ophthalmol 1988;105–177.Google Scholar
  3. 3.
    Schepens CL. Letter to the Editor. Ophthalmology 1987;94:201.PubMedGoogle Scholar
  4. 4.
    DeBustros S, Michels RG. Surgical treatment of retinal detachments complicated by proliferative vitreoretinopathy. Am J Ophthalmol 1984;98:694.Google Scholar
  5. 5.
    Machemer R. Massive preretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 1977;75:556.PubMedGoogle Scholar
  6. 6.
    Sternberg P, Machemer R. Results of conventional vitreous surgery for proliferative vitreoretinopathy. Am J Ophthalmol 1985; 100:141.PubMedGoogle Scholar
  7. 7.
    Parke DW II, Aaberg TM. Intraocular argon laser photocoagulation in the management of severe proliferative vitreoretinopathy. Am J Ophthalmol 1984;97:434.PubMedGoogle Scholar
  8. 8.
    Scott JD. The treatment of massive vitreous retraction by the separation of preretinal membranes using liquid silicone. Med Probi Ophthalmol 1975;15:285.Google Scholar
  9. 9.
    Lean JS, Leaver PK, Cooling RJ, McLeod D. Management of complex retinal detachments by vitrectomy and fluid silicone exchange. Trans Ophthalmol Soc UK 1982;102:203.PubMedGoogle Scholar
  10. 10.
    Diddie KR, Stern WH, Ober RR, et al. Intraocular silicone oil for recurrent proliferative vitreoretinopathy in vitrectomized eyes. Invest Ophthalmol Vis Sci (ARVO Abstracts) 1983;24:173.Google Scholar
  11. 11.
    Chang S, Coleman DJ, Lincoff H, et al. Perfluoropropane gas in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1984;98:180.PubMedGoogle Scholar
  12. 12.
    McCuen BW, Landers MB, Machemer R. The use of silicone oil following vitrectomy for retinal detachment with massive proliferative vitreoretinopathy. Ophthalmology 1985;92:1029.PubMedGoogle Scholar
  13. 13.
    Cox MS, Trese MT, Murphy PL. Silicone oil for advanced proliferative vitreoretinopathy. Ophthalmology 1985;93:646.Google Scholar
  14. 14.
    Stern WH, Johnson RN, Irvine AR, et al. Extended retinal tamponade in the treatment of retinal detachment with proliferative vitreoretinopathy. Br J Ophthalmol 1986;70:911.PubMedCrossRefGoogle Scholar
  15. 15.
    Sell CH, McCuen BW, Landers MB, Machemer B. Long term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am J Ophthalmol 1987;103:24.PubMedGoogle Scholar
  16. 16.
    Azen SP, Irvine AR, Davis MD, et al. The validity of photographic documentation of proliferative vitreoretinopathy. In preparation.Google Scholar
  17. 17.
    Lean JS, Stern WH, Irvine AR, et al. The classification of proliferative vitreoretinopathy used in The Silicone Study. In preparation.Google Scholar
  18. 18.
    Tano Y, Sugita G, Abrams G, Machemer R: Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol 1980;89:131.PubMedGoogle Scholar
  19. 19.
    Blumenkranz MS, Ophri A, Claflin A, Hajeck A. Fluorouracil for the treatment of massive periretinal proliferations. Am J Ophthalmol 1982;94:458.PubMedGoogle Scholar
  20. 20.
    Stern WH, Lewis GP, Erickson PA, et al. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol 1983;96:33.PubMedGoogle Scholar
  21. 21.
    Heath TD, Lopez NG, Lewis GP, Stern WH. Fluoropyrimidine treatment of ocular cicatricial disease. Invest Ophthalmol Vis Sci 1986;27:940.PubMedGoogle Scholar
  22. 22.
    Kirmani M, Santana M, Sorgente N, et al. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy. Control by daunomycin. Retina 1983;3:269.PubMedCrossRefGoogle Scholar
  23. 23.
    Lemor M, Yeo JH, Glaser BM. Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol 1986;104:1226.PubMedGoogle Scholar
  24. 24.
    Johnson RN, Balyeat E, Stern WH. Heparin prophylaxis for intraocular fibrin. Ophthalmology 1987;94:597.PubMedGoogle Scholar
  25. 25.
    Lambrou FH, Snyder RW, Williams GA. Use of tissue plasminogen activator in experimental hyphema. Arch Ophthalmol 1987;105:995.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • Walter H. Stern
  • John S. Lean
  • The Silicone Study Group

There are no affiliations available

Personalised recommendations